Vimarsana
Biggest News Aggregation in the World

Page 2 - Kumar Budur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kumar Budur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kumar Budur Today - Breaking & Trending Today

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript - Vimarsana News

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript February 22, 2024 Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.74. Harmony Biosciences Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]

Source: yahoo.com
Pitolisant Granted Orphan Drug Status for Prader-Willi Syndrome - Vimarsana News

Pitolisant Granted Orphan Drug Status for Prader-Willi Syndrome

Prader-Willi syndrome is a rare genetic disease characterized by severe hyperphagia that can lead to potentially life-threatening obesity.

Source: empr.com
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript - Vimarsana News

Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript

HRMY earnings call for the period ending December 31, 2023.

Source: yahoo.com
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript - Vimarsana News

Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript

HRMY earnings call for the period ending December 31, 2023.

Source: fool.com
HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME - Vimarsana News

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug...